Gossamer Bio Inc (GOSS)
0.8022
-0.02
(-2.80%)
USD |
NASDAQ |
Apr 18, 14:40
Gossamer Bio Shares Outstanding: 225.58M for Feb. 27, 2024
Shares Outstanding Chart
Historical Shares Outstanding Data
Date | Value |
---|---|
February 27, 2024 | 225.58M |
December 31, 2023 | 225.41M |
November 03, 2023 | 225.41M |
September 30, 2023 | 225.41M |
August 03, 2023 | 225.32M |
July 24, 2023 | 225.32M |
June 30, 2023 | 95.45M |
May 04, 2023 | 95.44M |
April 18, 2023 | 95.44M |
April 12, 2023 | 95.44M |
March 31, 2023 | 95.44M |
March 10, 2023 | 94.98M |
December 31, 2022 | 94.42M |
October 31, 2022 | 94.48M |
September 30, 2022 | 93.91M |
August 05, 2022 | 93.95M |
July 15, 2022 | 93.77M |
June 30, 2022 | 76.74M |
May 05, 2022 | 77.12M |
April 19, 2022 | 77.11M |
March 31, 2022 | 76.55M |
February 25, 2022 | 76.48M |
December 31, 2021 | 75.75M |
November 04, 2021 | 76.46M |
September 30, 2021 | 75.30M |
Date | Value |
---|---|
August 05, 2021 | 75.99M |
June 30, 2021 | 74.84M |
May 03, 2021 | 75.91M |
April 19, 2021 | 75.91M |
March 31, 2021 | 74.49M |
February 19, 2021 | 75.53M |
December 31, 2020 | 73.87M |
November 05, 2020 | 75.93M |
September 30, 2020 | 72.48M |
August 06, 2020 | 71.99M |
June 30, 2020 | 71.97M |
May 21, 2020 | 75.79M |
May 07, 2020 | 66.36M |
April 22, 2020 | 66.35M |
March 31, 2020 | 62.09M |
March 18, 2020 | 66.34M |
December 31, 2019 | 61.64M |
November 06, 2019 | 60.98M |
September 30, 2019 | 60.98M |
August 05, 2019 | 60.47M |
June 30, 2019 | 60.47M |
May 08, 2019 | 65.89M |
May 02, 2019 | 65.89M |
April 22, 2019 | 65.89M |
March 31, 2019 | 60.03M |
Shares Outstanding Definition
The volume of stock shares issued by the company and in the hands of the public. This number entails how much is being traded in the open market. A decreasing shares outstanding over time may be the result of company buybacks. Companies frequently make stock buybacks and retire those buybacks as treasury stock.
Shares Outstanding Range, Past 5 Years
60.47M
Minimum
Jun 30 2019
225.58M
Maximum
Feb 27 2024
95.20M
Average
75.93M
Median
Nov 05 2020
Shares Outstanding Benchmarks
Amicus Therapeutics Inc | 295.38M |
TG Therapeutics Inc | 154.42M |
Replimune Group Inc | 61.39M |
89bio Inc | 93.50M |
Moderna Inc | 382.88M |